218 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by LRI Investments LLC

LRI Investments LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the first quarter, Holdings Channel.com reports. The firm purchased 218 shares of the company’s stock, valued at approximately $69,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in HCA Healthcare by 0.4% during the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares in the last quarter. Sanders Capital LLC increased its position in shares of HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after buying an additional 170,560 shares in the last quarter. Royal Bank of Canada grew its position in shares of HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after acquiring an additional 1,183,890 shares during the period. Finally, Capital World Investors lifted its stake in HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HCA has been the subject of several research analyst reports. Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Barclays increased their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Oppenheimer boosted their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $335.00 price target on shares of HCA Healthcare in a research report on Wednesday. Four research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $339.72.

Insider Buying and Selling

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the completion of the transaction, the senior vice president now directly owns 19,612 shares in the company, valued at approximately $6,397,042.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the sale, the senior vice president now owns 22,365 shares of the company’s stock, valued at $6,977,880. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the sale, the senior vice president now owns 19,612 shares in the company, valued at $6,397,042.16. The disclosure for this sale can be found here. In the last ninety days, insiders sold 12,397 shares of company stock valued at $3,921,929. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Stock Performance

NYSE:HCA traded up $1.99 during mid-day trading on Friday, reaching $354.78. The company’s stock had a trading volume of 1,215,941 shares, compared to its average volume of 1,679,664. The company has a current ratio of 1.06, a quick ratio of 1.02 and a debt-to-equity ratio of 27.11. The firm’s fifty day moving average price is $330.12 and its two-hundred day moving average price is $323.11. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $356.30. The stock has a market cap of $92.92 billion, a P/E ratio of 17.69, a PEG ratio of 1.35 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. During the same period in the previous year, the business earned $4.29 EPS. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. On average, equities analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.